Tag: S Aparna
India gets a national policy on Pharma-MedTech R&D, Rs 5,000 Crore...
We need to transform Indian Pharma & MedTech sectors from a cost-based to a value-based & innovation-based industry, outlines Health Minister Dr Mansukh Mandaviya
India needs to ramp up its triple advantage of cost, quality...
S. Aparna emphasized collaboration between large companies and start-ups, industry and academia collaboration by making public research more accessible and collaboration across sectors
Govt has allocated over Rs.10,000 crores in PLI scheme for bulk...
Citing the recent UNCTAD report, DV Sadananda Gowda, Minister for Chemicals and Fertilizers also pointed out India’s positive FDI growth even with a decline in FDI of 42% globally.....................
Medical devices a sunrise sector, to be US$ 50 bn by...
S Aparna, Secretary, Department of Pharmaceuticals mentioned that her Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry....................